# A Study of HW243040 in Healthy Participants

> **NCT07737496** · PHASE1 · RECRUITING · sponsor: **Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.** · enrollment: 98 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HW243040
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07737496
- **Lead sponsor:** Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-20
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2026-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07737496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07737496, "A Study of HW243040 in Healthy Participants". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07737496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*